octanoic acid
OCTANOIC ACID (Caprylic acid) eight-carbon saturated fatty acid belongs to the class of mediumchain saturated fatty acids. OCTANOIC ACID found naturally in the milk of various mammals, and as a minor constituent of coconut oil and palm kernel oil. Caprylic acid is used commercially in the production of esters used in perfumery and also in the manufacture of dyes. Caprylic acid is an antimicrobial pesticide used as a food contact surface sanitizer in commercial food handling establishments on dairy equipment, food processing equipment, breweries, wineries, and beverage processing plants. It is also used as disinfectant in health care facilities, schools/colleges, animal care/veterinary facilities, industrial facilities, office buildings, recreational facilities, retail and wholesale establishments, livestock premises, restaurants, and hotels/motels. In addition, caprylic acid is used as an algaecide, bactericide, and fungicide in nurseries, greenhouses, garden centers, and interiorscapes on ornamentals. Products containing caprylic acid are formulated as soluble concentrate/liquids and ready-to-use liquids. — NCATS
Clinical trial activity
9 trials · 15 clinical orgs · 0 marketing orgs
Earliest trial started Oct 1, 2004 (NCT00142805)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
SMILES
CCCCCCCC(O)=O- Mol. weight
- 144.2114 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCaprylic acid ↗
- NCATSOBL58JN025 ↗
- ChEMBLCHEMBL324846 ↗
Also known as
- caprylic acid
- caprylic acid
- caprylic acid
- caprylic acid
- caprylic acid
- caprylic acid, 14c-labeled
- caprylic acid, aluminum salt
- caprylic acid, ammonia salt
- caprylic acid, barium salt
- caprylic acid, cadmium salt
- caprylic acid, calcium salt
- caprylic acid, cesium salt
- caprylic acid, chromium(+2) salt
- caprylic acid, cobalt salt
- caprylic acid, copper(+2) salt
- caprylic acid, copper salt
- caprylic acid, iridum(+3) salt
- caprylic acid, iron(+3) salt
- caprylic acid, lanthanum(+3) salt
- caprylic acid, lead(+2) salt
- caprylic acid, lithium salt
- caprylic acid, manganese salt
- caprylic acid, nickel(+2) salt
- caprylic acid, potassium salt
- caprylic acid, ruthenium(+3) salt
- caprylic acid, sodium salt
- caprylic acid, sodium salt, 11c-labeled
- caprylic acid, tin(+2) salt
- caprylic acid, tin salt
- caprylic acid, zinc salt
- caprylic acid, zirconium(+4) salt
- caprylic acid, zirconium salt
- capryloate
- capryloate
- caprylsaeure
- caprylsaeure
- n-octanoic acid
- n-octanoic acid
- n-octoic acid
- n-octoic acid
- n-octylic acid
- n-octylic acid
- octanoate
- octanoate
- octanoate
- octanoic acid
- octanoic acid
- octanoic acid
- octanoic acid
- octanoic acid
- octanoic acid
- octanoic acid
- octanoic acid
- octic acid
- octic acid
- octoic acid
- octoic acid
- octylic acid
- octylic acid
- sodium caprate
- sodium caprylate
- sodium caprylate
- sodium caprylate
- sodium octanoate
- sodium octanoate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02602158 | Early Phase 1 (Phase 1) | Oct 1, 2015 | University of Zurich |
| NCT01864525 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2013 | National Institute on Deafness and Other Communication Disorders (NIDCD), Syracuse University |
| NCT03467737 | N/A | Dec 1, 2012 | Baylor University, Purdue University |
| NCT01433016 | Phase 2 | Nov 1, 2011 | Exalenz Bioscience LTD., Hebrew University, Henry Ford Health System, Medical University of South Carolina, Northwestern University, University of Toronto |
| NCT01468948 | Phase 1 | Oct 28, 2011 | National Institute of Neurological Disorders and Stroke (NINDS) |
| NCT01244503 | Phase 2 | Feb 1, 2011 | Exalenz Bioscience LTD., Virginia Commonwealth University |
| NCT00848172 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2009 | National Institute of Neurological Disorders and Stroke (NINDS) |
| NCT00355550 | Phase 2 | Jul 1, 2006 | Cerecin, Psychologix, Inc. |
| NCT00142805 | Phase 2 | Oct 1, 2004 | Cerecin |
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cerecin | For profit | 2 | 2 | 1 | 2004 |
| Exalenz Bioscience LTD. | For profit | 2 | 1 | 1 | 2011 |
| National Institute of Neurological Disorders and Stroke (NINDS) | Government | 2 | 2 | 2 | 2009 |
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Hebrew University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Henry Ford Health System | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Medical University of South Carolina | Academic/Hospital | 1 | 0 | 1 | 2011 |
| National Institute on Deafness and Other Communication Disorders (NIDCD) | Government | 1 | 0 | 1 | 2013 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Psychologix, Inc. | For profit | 1 | 0 | 1 | 2006 |
| Purdue University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Syracuse University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| University of Toronto | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Zurich | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Virginia Commonwealth University | Academic/Hospital | 1 | 1 | 1 | 2011 |